Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.93 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL195676 | 0.97 | TP53 (1.00) | TP53MEN1ALDH1A1TSHRKMT2A | |
| Sulfuric Acid SCHEMBL10426486 | 0.85 | TP53 (0.78) | TP53ALDH1A1 | |
| Sulfuric Acid SCHEMBL10426485 | 0.85 | TP53 (0.78) | TP53ALDH1A1 | |
| Sulfuric Acid SCHEMBL8736504 | 0.84 | TP53 (0.77) | TP53MEN1ALDH1A1TSHRKMT2A | |
| Sulfuric Acid SCHEMBL16037906 | 0.83 | TP53 (0.65) | TP53 | |
| Hydrochloric Acid SCHEMBL11848392 | 0.78 | TP53 (0.53) | TP53ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL196471 | 0.78 | TP53 (0.53) | TP53ALDH1A1TSHR | |
| Vinylsulfonic Acid SCHEMBL9515785 | 0.77 | TP53 (0.65) | TP53 | |
| Sulfuric Acid SCHEMBL15309084 | 0.77 | TP53 (0.65) | TP53MEN1ALDH1A1TSHRKMT2A | |
| Sulfuric Acid SCHEMBL15611632 | 0.76 | TP53 (0.65) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | SOLUGEN, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20240368452-A1 | COMPOSITIONS AND METHODS FOR THE DISSOLUTION OF IRON SULFIDE | SOLUGEN, INC. (US) | 2024-11-07 | — | — | US | disclosed |
| CN-115110314-A | Method for preventing reactive dye dyed flame-retardant textile from washing formaldehyde and causing color change to be uneven | 新乡市新星特种织物有限公司 | 2022-09-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | MGAT2, SLC7A11, CA1 | TP53 1524/4885MEN1 2493/4885ALDH1A1 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.